CLEC16A-GRIN2A Fusion FISH Probe
The CLEC16A-GRIN2A Fusion FISH Probe is used to confirm a fusion of the CLEC16A and GRIN2A genes. The fusion of the CLEC16A and GRIN2A genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CLEC16A-GRIN2A-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-GRIN2A-20-AQAQ | 20 (40 μL) | 200 μL |
|
GRIN2A Gene Summary
This gene encodes a member of the glutamate-gated ion channel protein family. The encoded protein is an N-methyl-D-aspartate (NMDA) receptor subunit. NMDA receptors are both ligand-gated and voltage-dependent, and are involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. These receptors are permeable to calcium ions, and activation results in a calcium influx into post-synaptic cells, which results in the activation of several signaling cascades. Disruption of this gene is associated with focal epilepsy and speech disorder with or without cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
Gene Name: Glutamate Ionotropic Receptor NMDA Type Subunit 2A
Chromosome: CHR16: 9847264 -10276611
Locus: 16p13.2
CLEC16A Gene Summary
This gene encodes a member of the C-type lectin domain containing family. Single nucleotide polymorphisms in introns of this gene have been associated with diabetes mellitus, multiple sclerosis and rheumatoid arthritis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
Gene Name: C-type Lectin Domain Containing 16A
Chromosome: CHR16: 11038344 -11276046
Locus: 16p13.13
Gene Diseases
The CLEC16A GRIN2A Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|